Amesite Announces Quarterly Revenue Increase of 2.4x in 10-Q Filing
Amesite (NASDAQ: AMST) reported significant growth in Q3/2025, with its AI-powered healthcare app NurseMagicTM generating 2.4x revenue increase compared to Q2/2025. The company achieved balanced revenue distribution between B2B and B2C sales, while successfully reducing operating expenses. Following paid subscription launch in Q2, user growth surged by 1340% in Q3.
The company expanded its B2B offerings with Teams Plus+ and is targeting the substantial U.S. healthcare market, including 16,700 Skilled Nursing and Home Health Care Facilities employing 1.38 million workers, and 8,514 hospice organizations with 407,692 workers. Recent developments include hospice segment expansion, HIPAA compliance implementation, and introduction of a higher-priced B2B tier.
Amesite (NASDAQ: AMST) ha registrato una crescita significativa nel terzo trimestre del 2025, con la sua app sanitaria basata sull'intelligenza artificiale NurseMagicTM che ha generato un aumento del fatturato di 2,4 volte rispetto al secondo trimestre del 2025. L'azienda ha raggiunto una distribuzione equilibrata del fatturato tra vendite B2B e B2C, riducendo con successo le spese operative. Dopo il lancio degli abbonamenti a pagamento nel secondo trimestre, la crescita degli utenti è aumentata del 1340% nel terzo trimestre.
L'azienda ha ampliato la sua offerta B2B con Teams Plus+ e punta al vasto mercato sanitario statunitense, che comprende 16.700 strutture di assistenza infermieristica specializzata e domiciliare con 1,38 milioni di lavoratori, oltre a 8.514 organizzazioni hospice con 407.692 operatori. Tra le novità recenti figurano l'espansione nel segmento hospice, l'implementazione della conformità HIPAA e l'introduzione di un livello B2B a prezzo più elevato.
Amesite (NASDAQ: AMST) reportó un crecimiento significativo en el tercer trimestre de 2025, con su aplicación de salud impulsada por IA NurseMagicTM generando un aumento de ingresos de 2.4 veces en comparación con el segundo trimestre de 2025. La compañía logró una distribución equilibrada de ingresos entre ventas B2B y B2C, mientras reducía exitosamente los gastos operativos. Tras el lanzamiento de la suscripción de pago en el segundo trimestre, el crecimiento de usuarios se disparó un 1340% en el tercer trimestre.
La empresa amplió su oferta B2B con Teams Plus+ y apunta al considerable mercado sanitario de EE.UU., que incluye 16,700 centros de enfermería especializada y atención médica domiciliaria con 1.38 millones de trabajadores, y 8,514 organizaciones de hospicio con 407,692 empleados. Los desarrollos recientes incluyen la expansión del segmento de hospicio, la implementación de cumplimiento HIPAA y la introducción de un nivel B2B de mayor precio.
Amesite (NASDAQ: AMST)는 2025년 3분기에 큰 성장을 기록했으며, AI 기반 헬스케어 앱 NurseMagicTM이 2025년 2분기 대비 수익이 2.4배 증가했습니다. 회사는 B2B와 B2C 매출을 균형 있게 분배했으며 운영비용도 성공적으로 절감했습니다. 2분기 유료 구독 출시 이후 3분기 사용자 수가 1340% 급증했습니다.
회사는 Teams Plus+를 통해 B2B 제품을 확장했으며, 138만 명의 근로자가 있는 16,700개의 전문 간호 및 가정 건강 관리 시설과 40만 7,692명의 근로자가 있는 8,514개의 호스피스 조직을 포함한 미국 헬스케어 시장을 목표로 하고 있습니다. 최근에는 호스피스 부문 확장, HIPAA 준수 도입, 고가 B2B 등급 도입 등의 발전이 있었습니다.
Amesite (NASDAQ : AMST) a enregistré une croissance significative au troisième trimestre 2025, avec son application de santé propulsée par l'IA NurseMagicTM générant une augmentation des revenus de 2,4 fois par rapport au deuxième trimestre 2025. L'entreprise a atteint une répartition équilibrée des revenus entre les ventes B2B et B2C, tout en réduisant avec succès ses dépenses d'exploitation. Après le lancement de l'abonnement payant au deuxième trimestre, la croissance des utilisateurs a bondi de 1340% au troisième trimestre.
L'entreprise a élargi son offre B2B avec Teams Plus+ et cible le marché important des soins de santé aux États-Unis, comprenant 16 700 établissements de soins infirmiers spécialisés et de soins à domicile employant 1,38 million de travailleurs, ainsi que 8 514 organisations d'hospices avec 407 692 employés. Les développements récents incluent l'expansion du segment hospice, la mise en conformité HIPAA et l'introduction d'un niveau B2B à prix plus élevé.
Amesite (NASDAQ: AMST) verzeichnete im dritten Quartal 2025 ein signifikantes Wachstum, wobei seine KI-gestützte Gesundheits-App NurseMagicTM einen 2,4-fachen Umsatzanstieg im Vergleich zum zweiten Quartal 2025 erzielte. Das Unternehmen erreichte eine ausgewogene Umsatzverteilung zwischen B2B- und B2C-Verkäufen und konnte gleichzeitig die Betriebskosten erfolgreich senken. Nach dem Start des kostenpflichtigen Abonnements im zweiten Quartal stieg das Nutzerwachstum im dritten Quartal um 1340%.
Das Unternehmen erweiterte sein B2B-Angebot mit Teams Plus+ und zielt auf den bedeutenden US-Gesundheitsmarkt ab, der 16.700 Pflege- und häusliche Gesundheitsversorgungseinrichtungen mit 1,38 Millionen Beschäftigten sowie 8.514 Hospizorganisationen mit 407.692 Mitarbeitern umfasst. Zu den jüngsten Entwicklungen zählen die Expansion im Hospizsegment, die Umsetzung der HIPAA-Konformität und die Einführung einer höherpreisigen B2B-Stufe.
- Revenue increased 2.4x from Q2/2025 to Q3/2025
- User growth of 1340% over Q3 following paid subscriptions launch
- Operating expenses reduced while scaling sales
- Successfully maintaining balanced B2B and B2C revenue distribution
- Rapid sales closure and onboarding process (days to weeks)
- New higher-priced tier introduced for B2B users
- Revenue was stable (flat) from Q1/2025 to Q2/2025
- Company still not profitable, though working towards it
Insights
Amesite shows 2.4x quarterly revenue growth with dual B2B/B2C strategy while reducing expenses, indicating promising path toward profitability.
Amesite's Q3/2025 financial results reveal a 2.4x revenue increase compared to Q2/2025, an impressive acceleration after relatively flat performance between Q1 and Q2. This growth comes while the company simultaneously reduced operating expenses – a rare and encouraging combination that suggests improving operational efficiency.
The revenue distribution is balanced evenly between B2B and B2C channels, providing diversification that reduces risk. The company's NurseMagic™ product is showing strong market traction with reported 1340% user growth following the launch of paid subscriptions in Q2. This substantial user acquisition rate suggests the product has found product-market fit within the nursing sector.
What's particularly promising is Amesite's focus on operational efficiency alongside growth. Many early-stage tech companies prioritize growth at all costs, but Amesite appears to be taking a more sustainable approach by managing margins and pursuing profitability. The company has executed targeted sales and marketing initiatives while implementing product enhancements that are driving revenue.
The company is strategically positioning itself in substantial markets: 16,700 Skilled Nursing and Home Health Care Facilities employing 1.38 million workers, 8,514 hospice organizations with 407,692 workers, plus access to 5.2 million RNs and 630,000 LPNs across the U.S. This represents a significant addressable market, especially as Amesite expands into growing segments like hospice care. The introduction of tiered pricing with a higher-priced B2B tier suggests a path to increasing average revenue per user while maintaining healthy margins.
Company Reports Accelerated Growth for both B2C and B2B, with Outstanding Customer Reviews into Q4
DETROIT, May 16, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced its flagship app NurseMagicTM generated 2.4x revenue from Q2/2025 to Q3/2025, even as the company continued to cut operating expenses.
Sarah Berman, Principal Financial and Accounting Officer, said, “Our revenues are presently evenly distributed between B2B and B2C sales. Following the launch of NurseMagicTM in Q4/2024, revenues were stable from Q1/2025 to Q2/2025. However, in Q3/2025, we had a significant increase of 2.4x in revenue, following execution of targeted sales and marketing motions and rollouts of product enhancements. We also further reduced expenses while scaling sales this past quarter, retaining our strong focus on achieving further operational efficiencies and managing margins to drive to profitability.”
Brandon Owens, VP of Sales, said, “We delivered Teams Plus+ to our B2B customers in direct response to their need for greater intensity of usage, and expect accelerated business demands for more services, given the feedback. Our product testimonials are our best sales assets, and we are closing sales and onboarding teams within days or weeks, because of the efficiency of our payments and onboarding workflows."
Madison Bush, Director of Corporate Operations, said, "We saw user growth of
Dr. Ann Marie Sastry, CEO and Founder, said, “We are confident that we can continue to deliver NurseMagicTM at an affordable price point to both B2C and B2B customers, while maintaining healthy margins – and look forward to more growth in Q4. Our outstanding customer feedback validates a strong product-market fit. With our nimble development process, we feel that we are in very good position to grow revenue efficiently, while delivering tiered services that enable us to expand into new segments opportunistically.”
Amesite is focused on delivering value in large, growing segments, including the 16,700 Skilled Nursing and Home Health Care Facilities in the U.S., employing 1.38 million workers, and 8,514 hospice organizations employing 407,692 workers. With a total of 5.2 million RNs and 630,000 LPNs in the U.S., and demand rising across Senior Living, Skilled Nursing, and Hospice, Amesite is positioned with solutions that meet real needs. Recent rollouts include delivering to the growing hospice segment, meeting HIPAA requirements for all users, and offering a new, higher-priced tier for B2B users.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
ir@amesite.com
FAQ
What was Amesite's (AMST) revenue growth in Q3 2025?
How much did Amesite's (AMST) user base grow in Q3 2025?
What is Amesite's (AMST) NurseMagic product?
What is the target market size for Amesite's (AMST) NurseMagic?
What new features did Amesite (AMST) add to NurseMagic in 2025?
